Investment objective & strategy
As of Jan. 28, 2026 · prospectusObjective. The Funds investment objective is long-term growth of capital.
Strategy. The Fund invests primarily in small and micro cap foreign and domestic companies. Under normal market conditions, we will invest the Funds net assets primarily in the equity securities, typically common stock, of foreign and domestic companies. These companies will typically have minimum market capitalizations of $100 million and up to a maximum market capitalization at the time of purchase of $5 billion or the market capitalization of the largest company in the Morgan Stanley Capital International (MSCI) ACWI Small Cap Index as of its most recent reconstitution date, whichever is greater. As of the 2025 reconstitution date, the market capitalization of companies included in the MSCI ACWI Small Cap Index ranged from $ 61 million to $ 35.436 billion. … The Fund invests primarily in small and micro cap foreign and domestic companies. Under normal market conditions, we will invest the Funds net assets primarily in the equity securities, typically common stock, of foreign and domestic companies. These companies will typically have minimum market capitalizations of $100 million and up to a maximum market capitalization at the time of purchase of $5 billion or the market capitalization of the largest company in the Morgan Stanley Capital International (MSCI) ACWI Small Cap Index as of its most recent reconstitution date, whichever is greater. As of the 2025 reconstitution date, the market capitalization of companies included in the MSCI ACWI Small Cap Index ranged from $ 61 million to $ 35.436 billion. The market capitalizations for the range of companies in the MSCI ACWI Small Cap Index are subject to change following MSCIs fourth quarter index review, which occurs on or around November of each year. The Fund may also invest a significant portion of its total assets in micro cap companies with market capitalizations below $1 billion (up to 90% under normal market conditions). The Fund will typically invest in securities issued by companies domiciled in at least three countries, including the United States. The Fund may invest a significant portion of its total assets in companies domiciled in foreign countries (under normal market conditions, we expect at least 40% of its assets to be invested outside the United States, or if conditions are not favorable, 30% of its assets to be invested outside the United States). Securities issued by foreign companies incorporated outside the United States whose securities are principally traded in the United States are not defined as foreign companies and are not subject to this limitation. The Fund may invest a significant amount of its total assets (5% to 50% under normal market conditions) at the time of purchase in securities issued by companies domiciled in emerging and frontier markets, which are those countries currently included in the MSCI EFM (Emerging + Frontier Markets) Index. These companies typically are located in the Asia-Pacific region, Eastern Europe, the Middle East, Central and South America, and Africa. We use a process of quantitative screening followed by bottom-up fundamental analysis to identify individual companies that we believe have outstanding long-term growth potential. We travel extensively to visit companies and expect to meet with senior management. We may also invest in growth companies that we believe have had a temporary setback and therefore have appealing valuation relative to their long-term growth potential. At times, we may invest in early stage companies with limited or no earnings history if we believe they have outstanding long-term growth potential. We may also invest in initial public offerings (IPOs). We do not use allocation models to restrict the Funds investments to certain regions, countries, sectors or industries. We may significantly shift Fund assets between asset classes, sectors, and geographic regions based on where we believe the best growth opportunities and valuations currently exist. The Fund may invest a large percentage of its assets (greater than 5%) in a particular region or market, including India, Asia, Japan, Europe and the United Kingdom. The Fund may invest a large percentage of its assets (greater than 5%) in a few sectors. As of the date of this Prospectus, these sectors were industrials, information technology, financials , health care , consumer discretionary, and consumer staples.
Top holdings
As of March 31, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| HEALTHEQUITY INC | — | $5.27M | 3.87% |
| ASPEED TECH | — | $5.27M | 3.87% |
| AU SMALL FINANCE | — | $4.75M | 3.49% |
| ENSIGN GROUP INC | — | $3.93M | 2.89% |
| MonotaRO Company, Ltd. | 3064 | $3.79M | 2.78% |
| DIPLOMA PLC COMMON STOCK | DPLM | $3.59M | 2.63% |
| RBC BEARINGS INC | — | $3.41M | 2.50% |
| NOVA LTD | — | $3.32M | 2.44% |
| BALCHEM CORP | — | $3.13M | 2.30% |
| STANDEX INTL CORP | — | $3.05M | 2.24% |
Portfolio moves
Dec 31, 2025 → Mar 31, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Wasatch Core Growth Fund · WGROX, WIGRX | 53% | 1.05% |
| Wasatch Small Cap Growth Fund · WAAEX, WIAEX | 35% | 1.05% |
| Wasatch Long/Short Alpha Fund · WALSX, WGLSX | 33% | 2.01% |
Advisers
| Firm | Role |
|---|---|
| Wasatch Advisors LP | Adviser |
Footnotes
- Expense ratio as of January 28, 2026, from the fund's prospectus.
- Net assets and holdings count as of March 31, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.